The
following potentially dilutive shares of common stock equivalents “on an as-converted basis” were excluded from the computation
of diluted net loss per share for the periods presented because including them would have had an antidilutive effect:
Schedule of Potentially Dilutive Shares Excluded from Computation of Net Loss Per Share
|
|
For
the Three and Six Months Ended
June 30, |
|
|
|
2025 |
|
|
2024 |
|
|
|
|
|
|
|
|
Common
stock warrants |
|
|
36,892 |
|
|
|
207,417 |
|
Common
stock options |
|
|
9,971 |
|
|
|
20,808 |
|
Restricted
stock units |
|
|
303,577 |
|
|
|
36,384 |
|
Total
potentially dilutive common share equivalents |
|
|
350,440 |
|
|
|
264,609 |
|
|